CD4 and arthritic joint disease: It was found that B29-induced CD4+CD25+Foxp3+ T cells could suppress arthritis in the proteoglycan-induced RA mice model both prophylactically and therapeutically, indicating these self-antigen-specific Treg cells could regulate immune disorder in vivo (83).